HLFG:MYXHong Leong Financial Group Bhd. Analysis
Data as of 2026-03-17 - not real-time
$15.46
Latest Price
3/10Risk
Risk Level: Low
Executive Summary
The stock trades at $15.46, which is more than three times the DCF‑derived fair value of $4.28, indicating a substantial overvaluation. RSI is at 100, signaling extreme overbought conditions, while the 20‑day SMA aligns with the current price, offering no technical support. The 30‑day volatility is recorded at 0% and beta near zero, suggesting price stability but also a lack of price movement momentum. However, the trend direction is flagged as bearish and volume is essentially flat at 83 shares, highlighting liquidity constraints. Fundamental metrics show modest revenue growth (7.6%) but thin margins – gross margin just 11% and operating margin under 2% – and free cash flow is negative. Debt‑to‑equity stands at an alarming 153%, underscoring balance‑sheet pressure.
Recent news notes that Executive Chairman Mark Allen has increased his stake dramatically, which could be interpreted as confidence in a turnaround. Yet the company pays no dividend and its payout ratio is effectively zero, limiting income‑oriented appeal. The consumer‑defensive sector provides some resilience, but exposure across the UK, Europe and APAC adds geographic complexity. Given the stark price‑to‑fair‑value gap, high leverage, and illiquid trading, the stock appears poorly positioned for short‑term upside. Investors may consider waiting for a clearer path to cash‑flow positivity or a significant price correction.
Recent news notes that Executive Chairman Mark Allen has increased his stake dramatically, which could be interpreted as confidence in a turnaround. Yet the company pays no dividend and its payout ratio is effectively zero, limiting income‑oriented appeal. The consumer‑defensive sector provides some resilience, but exposure across the UK, Europe and APAC adds geographic complexity. Given the stark price‑to‑fair‑value gap, high leverage, and illiquid trading, the stock appears poorly positioned for short‑term upside. Investors may consider waiting for a clearer path to cash‑flow positivity or a significant price correction.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 7/10
Key Factors
- RSI at 100 indicating extreme overbought
- Price over three times DCF fair value
- Very low trading volume creating liquidity risk
Medium Term
1–3 yearsNeutral
Model confidence: 6/10
Key Factors
- Insider buying by Executive Chairman
- Defensive consumer sector offering some stability
- High debt‑to‑equity ratio limiting financial flexibility
Long Term
> 3 yearsNeutral
Model confidence: 5/10
Key Factors
- Potential for operational improvements to lift margins
- Broad geographic footprint diversifying revenue sources
- Continued lack of dividend and negative free cash flow
Key Metrics & Analysis
Financial Health
Revenue Growth7.60%
Profit Margin0.94%
P/E Ratio24.2
ROE12.88%
ROA4.86%
Debt/Equity153.49
P/B Ratio3.4
Op. Cash Flow$59.7M
Free Cash Flow$-30280000
Technical Analysis
TrendBearish
RSI100.0
Support$15.46
Resistance$15.46
MA 20$15.46
MA 50$15.46
MA 200$15.46
MACDNeutral
VolumeStable
Fear & Greed Index81.55
Valuation
Fair Value$4.28
GradeOvervalued
TypeValue
Risk Assessment
00
Sector RiskLow
Reg. RiskLow
Geo RiskMedium
Currency RiskMedium
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.